Form 8-K - Current report:
SEC Accession No. 0001213900-23-014316
Filing Date
2023-02-24
Accepted
2023-02-24 16:05:54
Documents
13
Period of Report
2023-02-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea174228-8k_chinapharma.htm   iXBRL 8-K 26027
2 PRESS RELEASE, DATED FEBRUARY 24, 2023. ea174228ex99-1_chinapharma.htm EX-99.1 5956
  Complete submission text file 0001213900-23-014316.txt   210933

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cphi-20230224.xsd EX-101.SCH 3269
4 XBRL LABEL FILE cphi-20230224_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE cphi-20230224_pre.xml EX-101.PRE 22387
7 EXTRACTED XBRL INSTANCE DOCUMENT ea174228-8k_chinapharma_htm.xml XML 3715
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34471 | Film No.: 23667013
SIC: 2834 Pharmaceutical Preparations